(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
3 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 5.40%
3.28% $ 1.260
@ $0.976
Emitido: 7 feb 2024 @ 15:19
Retorno: 29.12%
Señal anterior: feb 7 - 13:02
Señal anterior:
Retorno: -0.80 %
Live Chart Being Loaded With Signals
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally...
Stats | |
---|---|
Volumen de hoy | 1.85M |
Volumen promedio | 8.91M |
Capitalización de mercado | 878.21M |
EPS | $0 ( 2024-02-27 ) |
Próxima fecha de ganancias | ( $-0.0900 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.04 |
ATR14 | $0.00700 (0.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Yu Alice Lin-tsing | Buy | 0 | |
2024-03-28 | Paganelli John A | Buy | 0 | |
2024-03-28 | Lachman Prem A | Buy | 0 | |
2024-03-28 | Pfenniger Richard C Jr | Buy | 0 | |
2024-03-28 | Krasno Richard M | Buy | 0 |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 12 318 025 | Sell: 0 |
Volumen Correlación
OPKO Health Inc Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OPKO Health Inc Correlación - Moneda/Commodity
OPKO Health Inc Finanzas
Annual | 2023 |
Ingresos: | $863.50M |
Beneficio Bruto: | $232.10M (26.88 %) |
EPS: | $-0.250 |
FY | 2023 |
Ingresos: | $863.50M |
Beneficio Bruto: | $232.10M (26.88 %) |
EPS: | $-0.250 |
FY | 2022 |
Ingresos: | $1.00B |
Beneficio Bruto: | $288.20M (28.70 %) |
EPS: | $-0.460 |
FY | 2021 |
Ingresos: | $1.77B |
Beneficio Bruto: | $581.52M (32.77 %) |
EPS: | $-0.0500 |
Financial Reports:
No articles found.
OPKO Health Inc
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico